Clinical Trials Directory

Trials / Completed

CompletedNCT04815109

Prospective Electroencephalography Evaluation of Sedation in COVID-19

Prospective Evaluation of Aggravated Sedation in COVID-19 ARDS Patients Using Electroencephalography

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Goethe University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Sedation of severe COVID-19 disease are often complicated. We try to find a correlate for this observation by encephalographic studies.

Detailed description

Sedation of critically ill ventilated coronavirus patients, continues to be a challenging issue. Also, neurological symptoms of severe COVID-19 disease have been described frequently. Difficulties in sedation of these patients have been discussed repeatedly. The aim of this study is to investigate whether an encephalographic correlate can be found. Appropriate processed encephalographic techniques have been used for anesthesia monitoring for many years. The aim of our study is to collect unrelated processed and raw EEG data of sedated COVID-19 patients and to investigate the correlation to the necessary sedation.

Conditions

Interventions

TypeNameDescription
OTHEREncephalography measurementEncephalography measurement and partially aggravated sedation.

Timeline

Start date
2021-04-01
Primary completion
2022-02-28
Completion
2022-06-30
First posted
2021-03-24
Last updated
2022-08-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04815109. Inclusion in this directory is not an endorsement.